News

The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research, today announced the 2025 Inherited Neuropathies Fellow through its Inherited Neuropathies Consortium (INC) alliance. The fellowship was awarded to Bopha Chrea, MD, a board-certified orthopedic surgeon at ...

The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research, is proud to announce the designation of Hani Kushlaf, MD, FAAN, FANA, FAANEM, at the University of Cincinnati Gardner Neuroscience Institute in Cincinnati, Ohio, as a ...

A newly published study led by CMTA’s Strategy to Accelerate Research (CMTA-STAR) Clinical Expert Board Co-Chair Professor Mary M. Reilly, MBE, MD, and colleagues explores how MRI can track disease progression in CMT1A and serve as a potential biomarker for ...

The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research, is proud to announce the designation of Hernan Gonorazky, MD, at The Hospital for Sick Children (SickKids) in Toronto, Ontario, as a CMTA Center of Excellence. Dr. ...

Today, the Charcot-Marie-Tooth Association (CMTA) announced a $210,000 investment to advance gene discovery and improve diagnostic success for people with Charcot-Marie-Tooth disease (CMT). Led by Andrea Cortese, MD, PhD, at University College London, this new CMTA Strategy To Accelerate Research ...